---
aliases: [PM, PMI, Philip Morris International]
tags: [actor, tobacco, consumer, smoke-free]
---

# Philip Morris

**Philip Morris International (PM)** — Global tobacco company pivoting to smoke-free products. Spun off from Altria in 2008, focuses on international markets (ex-US). Leading smoke-free transition with IQOS heated tobacco and Zyn nicotine pouches.

---

## Quick stats

| Metric | Value |
|--------|-------|
| Ticker | PM |
| Market cap | ~$275B |
| FY 2025 revenue | $40.6B |
| Smoke-free % of revenue | **41.5%** (up from 24.2% in 2020) |
| Key products | IQOS, Zyn, Marlboro |
| Employees | ~82,000 |

---

## Smoke-free transition

| Year | Smoke-free % of revenue |
|------|------------------------|
| 2020 | 24.2% |
| 2025 | **41.5%** |
| Target | Majority by late 2020s |

**IQOS:** Heated tobacco system, ~155B units shipped (2025), +11% YoY.

**Zyn:** Acquired Swedish Match (2022) for $16B. Nicotine pouches, fastest-growing category.

---

## Charts

![[pm-price.png]]
*PM's smoke-free pivot rewarded shareholders — +175% since 2020 vs Altria's +80%. Divergence accelerated in 2024 as IQOS/Zyn growth became clear.*

![[pm-fundamentals.png]]
*Revenue grew from ~$7.5B to $10.5B quarterly (2018-2025). Net income volatile — 2024 dip from Swedish Match integration costs, now recovering.*

---

## Related

- [[Altria]] — US tobacco (former parent)
- [[British American Tobacco]] — Competitor
- [[Swedish Match]] — Acquired 2022

---

## Earnings

### Q4 2025 (Feb 6, 2026)

| Metric | Actual | Expected |
|--------|--------|----------|
| Q4 EPS | $1.70 | $1.70 (in-line) |
| Q4 Revenue | $10.36B | $10.38B (miss) |
| FY 2025 EPS | **$7.54** (+15% YoY) | — |
| Operating margin | 40.4% | — |
| 2026 EPS guidance | $8.38-$8.53 (+11-13%) | — |

**Smoke-free segment:** Q4 shipment volumes +8.5% YoY, cigarette volumes -2.2%. Smoke-free now 41% of revenue.

Fifth consecutive year of volume growth. Stock -2% premarket on weaker-than-expected FY26 profit guidance.
